Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Global Health Limited (NSE: MEDANTA), ISIN INE474Q01031 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MEDANTA last traded at ₹1427.85 (+2.90%), with a 52-week range of ₹956.00 to ₹1544.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 33.00%, FIIs 9.92%, DIIs 17.01%, mutual funds 15.97%.
EquiSense Score (ECS): 85/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.